IMF Videos Search Content For Care Partner (360) Patient (356) Healthcare Provider (216) Healthcare Professional (213) Series - Any - About the IMF (2) ASCO/EHA (71) ASH (102) Ask Dr. Durie (149) Black Swan Research Initiative (7) Community Workshops (5) Emerging Therapies (18) Facebook Live (22) Health Equity (14) IMF History (3) IMWG (12) Inspirational (15) Living Well with Myeloma (34) Myeloma in a Minute (26) Myeloma Made Simple (15) Myeloma University (12) NLB Webcasts (1) Patient & Family Webinar (11) Q&A (22) Recent News and Developments (7) Treatments (3) Trending Searches in Myeloma (4) Topics Clinical Trials (188) Financial Considerations (15) Frontline Therapy (84) Health Equity (35) Inspirational Stories (23) Insurance (6) Lab & Imaging Tests (73) Lifestyle (48) Mental & Emotional Health (30) Myeloma 101 (61) Myeloma in the News (9) Public Policy & Advocacy (17) Q&A's (44) Recorded Seminars & Workshops (15) Recorded Webinars (25) Relapse/Refractory Myeloma (139) Research Updates (196) Symptom Management (117) Myeloma Stage Early Relapse (1–3 Lines of Therapy) (151) High-Risk Myeloma (98) High-risk Smoldering Myeloma (72) Late Relapse (4–6 Lines of Therapy) (162) MGUS (89) Newly Diagnosed (Pre-Treatment or First Treatment) (160) Smoldering Myeloma (112) Types of Therapy Immunomodulatory drugs (IMiDs) (96) Immunotherapies (CAR T; BiTE, etc.) (163) Monoclonal antibodies (80) Proteasome inhibitors (67) Stem cell transplant (85) Steroids (64) Supportive Care (154) Year Published 2026 (53) 2025 (107) 2024 (93) 2023 (92) 2022 (36) 2021 (31) 2020 (13) 2019 (36) 2018 (21) 2017 (30) 2016 (24) 2015 (30) Trusted Voices Dr. Brian GM Durie (144) Dr. Joseph Mikhael (109) Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO (30) Dr. María-Victoria Mateos (7) Donna Catamero, ANP-BC, OCN, CCRC (5) Dr. Urvi A. Shah (5) Dr. Saad Usmani (4) Dr. Sigurður Kristinsson (4) Dr. Shaji Kumar (3) Dr. S. Vincent Rajkumar (1) Dr. Sagar Lonial (1) Dr. Tom Martin (1) Heather Cooper Ortner (1) Sort Newest firstOldest firstA -> ZZ -> ARelevance Are Clinical Trials Safe for Multiple Myeloma? (In Less Than a Minute) March 19, 2026 Early Signs of Multiple Myeloma: Symptoms, MGUS, and When to See a Doctor March 12, 2026 Living Well With Myeloma: Movement for Myeloma Patients and Care Partners March 10, 2026 Living Well with Myeloma ASH 2025 Myeloma Update: Bispecific Antibodies & 3-Year Remission Data February 26, 2026 Recent News and Developments Top 5 CAR T-cell Therapy Breakthroughs from ASH 2025 February 18, 2026 Recent News and Developments What Is Multiple Myeloma? Explained Clearly for Those Who Are Newly Diagnosed February 12, 2026 Myeloma Made Simple Multiple Myeloma Q&A: CAR T-cell Therapy, Steroids, Remission vs Cure, Kidneys, Bone Health, & More January 29, 2026 A Message to the Myeloma Community: IMF’s President and CEO Shares Her Priorities and Hope for the Future January 27, 2026 About the IMF Talquetamab + Teclistamab Show Promising Efficacy in Relapsed/Refractory Multiple Myeloma with EMD January 23, 2026 ASH Kilimanjaro Study: Etentamig Plus Pomalidomide-Dexamethasone Shows Robust Efficacy in Relapsed Myeloma January 21, 2026 ASH CARTITUDE-4: Exceptional Long-Term Outcomes with Cilta-cel in Standard-Risk Relapsed Myeloma January 20, 2026 ASH Anitocabtagene Autoleucel iMMagine-1 Trial: Exceptional Safety and Durability in Relapsed Myeloma January 16, 2026 ASH Load More
